UBS Group’s iPath Long Enhanced MSCI Emerging Markets Index ETN EMLB Stock Holding History

UBS Group’s Portfolio EMLB Stock Details EMLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-318	Closed	-$21K	–	8502
2017 Q3	$21K	Hold	318	–	–	﹤0.01%	6441
2017 Q2	$17K	Hold	318	–	–	﹤0.01%	6447
2017 Q1	$15K	Hold	318	–	–	﹤0.01%	6384
2016 Q4	$12K	Hold	318	–	–	﹤0.01%	6848
2016 Q3	$13K	Hold	318	–	–	﹤0.01%	6642
2016 Q2	$11K	Hold	318	–	–	﹤0.01%	6762
2016 Q1	$11K	Hold	318	–	–	﹤0.01%	6644
2015 Q4	$9K	Hold	318	–	–	﹤0.01%	7406
2015 Q3	$16K	Sell	318 -89	-22%	-$4.48K	﹤0.01%	6953
2015 Q2	$21K	Hold	407	–	–	﹤0.01%	6856
2015 Q1	$20K	Sell	407 -46	-10%	-$4.24K	﹤0.01%	7012
2014 Q4	$21K	Buy	+453	New	+$42.9K	﹤0.01%	7650

Other funds holding EMLB

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group's EMLB Position: Q4 2017 in Review

UBS Group sold out of iPath Long Enhanced MSCI Emerging Markets Index ETN (EMLB) in Q4 2017, closing a stake of 318 shares — an estimated $21K sold.

UBS Group first reported a position in EMLB in Q4 2014 and held it in 12 quarters. The position peaked at $21K in Q3 2017. 1 fund tracked by Wall St. Rank holds EMLB as of Q4 2017.

UBS Group reported no remaining iPath Long Enhanced MSCI Emerging Markets Index ETN position as of Q4 2017 after selling out during the quarter.
UBS Group sold 318 iPath Long Enhanced MSCI Emerging Markets Index ETN shares in Q4 2017, an estimated $21K.
UBS Group first reported a position in iPath Long Enhanced MSCI Emerging Markets Index ETN in Q4 2014 and held it in 12 quarters.
UBS Group's iPath Long Enhanced MSCI Emerging Markets Index ETN position peaked at $21K in Q3 2017.
1 fund tracked by Wall St. Rank held iPath Long Enhanced MSCI Emerging Markets Index ETN as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.